A team of researchers at the Sant Pau Research Institute (IR Sant Pau) has demonstrated that the plasma biomarker p-tau217, obtained through a simple blood test, can predict the clinical progression ...
Alzheimer's disease is a progressive and debilitating condition that slowly robs a person of their memories and personality. Alzheimer's disease is a form of dementia that produces various symptoms ...
The final stages of Alzheimer’s disease represent one of the most challenging periods for families watching their loved ones navigate this devastating condition. Understanding the critical signs that ...
Eisai Limited ("Eisai") and Biogen Canada Inc. are pleased to receive Canada's Drug Agency (CDA-AMC)'s final positive ...
Laura holds a Master's in Experimental Neuroscience and a Bachelor's in Biology from Imperial College London. Her areas of expertise include health, medicine, psychology, and neuroscience. Laura holds ...
Families waiting for new Alzheimer’s treatments are about to get a wave of data. Eight Phase 3 clinical trials, each testing a different drug or intervention, are scheduled to reach their primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results